Bipolar disorder, schizophrenia, and metabolic syndrome

American Journal of Psychiatry

Volumn 170, Issue 8, 2013, Pages 927-928

  Bartoli, Francesco ^a   Carrà, Giuseppe ^a   Crocamo, Cristina ^a   Carretta, Daniele ^a   Clerici, Massimo ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ALCOHOL CONSUMPTION; BIPOLAR DISORDER; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG USE; FEEDING BEHAVIOR; HEALTH BEHAVIOR; HUMAN; LETTER; LIFESTYLE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SMOKING HABIT;

EID: 84883381450     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2013.13040447     Document Type: Letter

References (13)

1. Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, Probst M, De Hert M: Metabolic syndrome and metabolic abnormalities in bipolar disorder: a metaanalysis of prevalence rates and moderators. Am J Psychiatry 2013; 170: 265-274
2. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M: Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders: a systematic review and meta-analysis. Schizophr Bull 2013; 39: 306-318
3. Baptista T, Serrano A, Uzcátegui E, ElFakih Y, Rangel N, Carrizo E, Fernández V, Connell L, de Baptista EA, Quiroz S, Uzcátegui M, Rondón J, Matos Y, Uzcátegui L, Gómez R, Valery L, Novoa- Montero D: The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: comparison with other drug treatments, drug-free psychiatric patients, firstdegree relatives and the general population in Venezuela. Schizophr Res 2011; 126: 93-102
4. Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K, Andreassen OA: The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 2007; 68: 917-923
5. Correll CU, Frederickson AM, Kane JM, Manu P: Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord 2008; 10: 788-797
6. Holt RI, Abdelrahman T, Hirsch M, Dhesi Z, George T, Blincoe T, Peveler RC: The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. J Psychopharmacol 2010; 24: 867-873
7. John AP, Koloth R, Dragovic M, Lim SC: Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust 2009; 190: 176-179
8. Khatana SA, Kane J, Taveira TH, Bauer MS, Wu WC: Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. PLoS One 2011; 6:e19298
9. Mattoo SK, Singh SM: Prevalence of metabolic syndrome in psychiatric inpatients in a tertiary care centre in north India. Indian J Med Res 2010; 131: 46-52
10. Sicras-Mainar A, Blanca-Tamayo M, Rejas-Gutiérrez J, Navarro- Artieda R: Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database. Eur Psychiatry 2008; 23: 100-108
11. Teixeira PJ, Rocha FL: The prevalence of metabolic syndrome among psychiatric inpatients in Brazil: Rev Bras Psiquiatr. 2007; 29: 330-336
12. van Winkel R, van Os J, Celic I, Van Eyck D, Wampers M, Scheen A, Peuskens J, De Hert M: Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program. J Clin Psychiatry 2008; 69: 1319-1327
13. Vuksan-Ćusa B, Jakovljević M, Sagud M, Mihaljević Peleš A, Marćinko D, Topić R, Mihaljević S, Sertić J: Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics. Psychiatry Res 2011; 189: 21-25